The ICEolate® platform is a series of specialized epicardial and endocardial cryoablation probes and catheters for use with CPSI’s SCN or PSN cryoablation systems for the treatment of various cardiac arrhythmias. ICEolate® probes include designs to conduct Pulmonary Vein Isolation, treatment of Atrial Fibrillation (AF), atrial flutter, ventricular tachyarrhythmia and other cardiovascular disease states. When combined with the SCN or PSN Systems, the ICEolate® disposable platform allows for the rapid delivery of a precise, full thickness (transmural), highly ablative thermal dose to targeted cardiac tissue in less than 2 minutes. The design and power of the system allows for delivery of this ablative dose either epicardially or endocardially in a fully beating heart, thereby eliminating the need for bypass or other form of stopping blood flow in the targeted region.
Disclaimer: CPSI Biotech’s technologies are currently Investigational Devices and are limited by Federal Law to Investigational Use Only.